Author: HAEMONETICS CORPORATION

Posted Date:

June 5, 2026

Haemonetics Updates Financial Reporting Segments

HAEMONETICS CORPORATION

June 5, 2026
Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference

HAEMONETICS CORPORATION

June 2, 2026
Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

HAEMONETICS CORPORATION

May 7, 2026
Haemonetics to Present at Bank of America 2026 Healthcare Conference

HAEMONETICS CORPORATION

May 5, 2026
New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

HAEMONETICS CORPORATION

April 24, 2026
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

HAEMONETICS CORPORATION

April 1, 2026
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

HAEMONETICS CORPORATION

March 30, 2026
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

HAEMONETICS CORPORATION

February 23, 2026
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

HAEMONETICS CORPORATION

February 20, 2026
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

HAEMONETICS CORPORATION

February 8, 2026